Skip to main content

Search This Blog

Lung Cancer

Posts

Low-Dose Computed Tomography Used to Screen First Responders for Lung Cancer - Cancer Therapy Advisor

Get link
Facebook
X
Pinterest
Email
Other Apps

- October 16, 2019

Low-Dose Computed Tomography Used to Screen First Responders for Lung Cancer Cancer Therapy Advisor

Groundbreaking Lung Cancer Research Abounds at Huntsman Cancer Institute and Intermountain Healthcare - OncLive

Get link
Facebook
X
Pinterest
Email
Other Apps

- October 16, 2019

Groundbreaking Lung Cancer Research Abounds at Huntsman Cancer Institute and Intermountain Healthcare OncLive

Low-Dose Computed Tomography Used to Screen First Responders for Lung Cancer - Cancer Therapy Advisor

Get link
Facebook
X
Pinterest
Email
Other Apps

- October 16, 2019

Low-Dose Computed Tomography Used to Screen First Responders for Lung Cancer Cancer Therapy Advisor

Low-Dose Computed Tomography Used to Screen First Responders for Lung Cancer - Cancer Therapy Advisor

Get link
Facebook
X
Pinterest
Email
Other Apps

- October 16, 2019

Low-Dose Computed Tomography Used to Screen First Responders for Lung Cancer Cancer Therapy Advisor

Low-dose lung cancer screenings can help save lives - Ashland Daily Press

Get link
Facebook
X
Pinterest
Email
Other Apps

- October 16, 2019

Low-dose lung cancer screenings can help save lives Ashland Daily Press

E-Cig Vaping Led to Lung Cancer in Mice: What Does This Mean for Humans? - EcoWatch

Get link
Facebook
X
Pinterest
Email
Other Apps

- October 16, 2019

E-Cig Vaping Led to Lung Cancer in Mice: What Does This Mean for Humans? EcoWatch

Family History Could Provide the Necessary Data to Anticipate Lung Cancer - www.oncnursingnews.com/

Get link
Facebook
X
Pinterest
Email
Other Apps

- October 16, 2019

Family History Could Provide the Necessary Data to Anticipate Lung Cancer www.oncnursingnews.com/

Powered by Blogger

Theme images by sandoclr

Popular Posts

Robert Zakar gives back to community

- September 30, 2023

hodgkin's lymphoma lung symptoms :: Article Creator Hodgkin - Bing News Lymphoma is a type of blood cancer that affects the body's ability to fight infection. It is a cancer of the lymphatic system ... The rising cancer treatment and technology known as CAR-T uses a patient's own blood cells to cure their malignancies. Eighty thousand people will be diagnosed with non-Hodgkin lymphoma – 20,000 will die from it. It usually strikes people in ... Regarding LP-284, Lantern presented data in non-Hodgkin's lymphomas at the Society of Hematologic Oncology Annual Meeting ... Non-Hodgkin's lymphoma is a form of cancer that affects a person's lymphatic system. Some research suggests that exposure to glyphosate may increase a person's risk of developing this type ... There is a link between non-Hodgkin's lymphoma (NHL) and smoking. Heavy smoking has an association with NHL, and t...

Association between radiotherapy and prognosis in patients with small cell carcinoma of the bladder undergoing bladder-sparing surgery

small cell lung cancer life expectancy stage 1 :: Article Creator First Patient With Small Cell Lung Cancer Dosed With Peluntamig The first patient with small cell lung cancer has been dosed in a trial of peluntamig (PT217) combined with chemotherapy. Phanes Therapeutics announces the first patient with small cell lung cancer dosed in a trial of peluntamig combined with chemotherapy in the SKYBRIDGE study. The first patient has been dosed in the clinical trial of peluntamig (PT217) in combination with chemotherapy, according to the drug's manufacturer, Phanes Therapeutics. The drug is being developed for the treatment of small cell lung cancer and neuroendocrine carcinoma, including neuroendocrine prostate cancer. The multi-center, first-in-human, open-label, phase 2/3 SKYBRIDGE study is investigating the safety, tolerability, pharmacokinetics and initial efficacy of peluntamig in patients with advanced or refractory cancers expr...

Exploring treatment options in cancer: tumor treatment strategies

- October 23, 2024

small cell carcinoma stage 4 life expectancy :: Article Creator Non-Small-Cell Lung Cancer Treatment By Stage After your lung cancer is diagnosed, the doctor will run tests to find out the size of the tumor and whether the cancer has spread to other parts of the body. This process is called staging. Knowing the stage of your disease is crucial because it will help you and your doctor choose the best course of treatment. Here's a look at the options for each stage. Keep in mind that no one can say for sure how your cancer will respond. Every person is different, and so is every cancer. Your doctor will make changes along the way to find what works best. STAGE 0 How It's Defined The cancer is only in the lining of your airways. Treatments Surgery: If your health is good overall, surgery is probably all you need. Depending on where the tumor is, your surgeon will suggest one of these procedures: Wedge resection: Cut out the tumor a...

Stage IV lung cancer survivor: Targeted therapy and surgery left me cancer-free

- March 19, 2025

early signs of lung cancer in non smoker :: Article Creator Lung Cancer Rising Among Non-smokers — Here's Why Cigarette smoking is by far the biggest risk factor for lung cancer, data shows — but in a surprising turn of events, the most common form of the disease is primarily found in non-smokers. Researchers at the International Agency for Research on Cancer (IARC) analyzed global trends in four main lung cancer subtypes: adenocarcinoma, squamous cell carcinoma, small-cell carcinoma and large-cell carcinoma. They found that adenocarcinoma has been the most "predominant subtype" in recent years, according to a press release summarizing the study. Younger females were found to be at a particularly high risk. US NAVY VETERAN BEATS CANCER WITH EXPERIMENTAL TREATMENT AND RELIANCE ON FAITH The study was published in The Lancet Respiratory Medicine earlier this month, based on global cancer data from 2022. Adenocarcinom...

Colorectal Tumors in Adolescents and Young Adults

- July 30, 2024

shore pulmonary doctors :: Article Creator Geisinger Jersey Shore Hospital Launches Pulmonary Rehabilitation Program JERSEY SHORE — Geisinger Jersey Shore Hospital has launched a Pulmonary Rehabilitation Program aimed at enhancing the health and well-being of people in the community. This comprehensive program offers specialized care and support to patients with pulmonary diseases. A team of experienced healthcare professionals provides personalized treatment plans tailored to each patient's unique needs. By offering a structured and supervised exercise regimen, education on disease management and lifestyle modification support, the program improves patients' respiratory function, reduces symptoms and enhances overall quality of life. "We are thrilled to bring this much-needed service to our local community," said Tammy Anderer, chief administrative officer at Geisinger Jersey Shore Hospital. "Our Pulmonary Rehabilitatio...

Durvalumab alone or with tremelimumab fails to extend OS in metastatic lung cancer

- November 18, 2018

A randomized phase 3 trial designed to compare durvalumab as monotherapy or in combination with tremelimumab with standard platinum-based chemotherapy for treatment-naive patients with metastatic non-small cell lung cancer failed to meet its primary endpoint of OS. The open-label, multicenter MYSTIC trial included patients with epidermal growth factor receptor and anaplastic lymphoma kinase wild-type, locally advanced or metastatic NSCLC . Researchers assigned patients to monotherapy with durvalumab (Imfinzi, AstraZeneca/MedImmune) , a human monoclonal antibody that binds to PD-L1; a combination of durvalumab and tremelimumab (AstraZeneca/MedImmune), a human monoclonal antibody that targets CTLA-4; or standard chemotherapy as first-line treatment. Neither experimental regimen conferred a statistically significant OS benefit compared with chemotherapy in the primary population of patients whose tumors expressed PD-L1 on 25% or more of their cancer cells (combination: HR = 0.85; 98.7...

Obstacles to Participation in Lung Cancer Trials - Cancer Therapy Advisor

- September 20, 2019

Obstacles to Participation in Lung Cancer Trials Cancer Therapy Advisor A survey of European patients with lung cancer identified obstacles to participation in clinical trials. We review key findings.

Oligometastatic cancer: What patients with stage IV cancer should know

- December 14, 2023

dr jose diaz pulmonologist :: Article Creator Released Hostages Face Potential Health Issues IE 11 is not supported. For an optimal experience visit our site on another browser. UP NEXT Inside the Israeli hospital dedicated to the rehab of soldiers injured since Hamas' October 7 attack 01:47 U.S. Tells Israel to end large-scale ground offensive in Gaza, two sources say 04:09 A journalist's perspective: Reporting on the Israel-Hamas war 09:57 Why some people are losing jobs over posts on Israel-Hamas war 03:44 Martin Fletcher speaks about if there can be peace in Israel and Gaza 03:54 Israel's Netanyahu says 'nothing will stop us' despite calls for truce 02:26 Bombardment of Khan Younis is so intense not all wounded can be rescued, medics say 01:03 Putin says there is no comparison between Gaza and Ukraine ...

Targeted Therapies in Non-Small Cell Lung Cancer - Curetoday.com

- November 06, 2021

Stephen Liu, MD: So, let's talk a little bit about the advancements in KRAS in non-small cell lung cancer, and the field of target therapies [that] evolved pretty rapidly. KRAS is not a new oncogene. This is something we've known about for a long time in terms of biomarkers. I think it was kind of one of the early ones. KRAS goes back to the 1950s, and Harold Varmus, who ran the NCI for a long time, won the Nobel Prize for his role in the discovery here. This is an oncogene that's not rare. It's present in maybe around one out of four lung cancers. And when we look at KRAS, we know that this is a transforming event, that this specific change within [a] normal cell will turn a normal lung cell into a lung cancer. Now, this is much more common in adenocarcinoma compared to squamous cancer. There's some association now with smoking, though that's a little complex there. The key here—and we talked about this repeatedly in our biomarker discussion—the details matter...

SSM Health Medical Minute – Lung cancer treatment

- November 14, 2018

Please enable Javascript to watch this video ST. LOUIS - November is Lung Cancer Awareness Month. SSSM Health in St. Louis is getting the word out that early screenings save lives. After decades of warnings about the dangers of smoking lung cancer is a still widespread problem. “Lung cancer is the number one cancer killer here in the United States for both men and women,” said Dr. Dani Tazbaz, SSM Health St. Mary’s Hospital. Lung cancer is usually not detected until symptoms develop by that time the disease is often advanced making a cure less likely, but a newly available CT Scan can diagnose the disease earlier when it is curable “If we detect non-small cell lung cancer stage one it can be curable and the treatment is surgery and for patients who cannot tolerate surgery we do radiation treatment,” said Tazbaz. Individuals with a significant history of tobacco should get the CT Scan. “The data showed that if we screened the patient early and we detect the disease early t...

Archive

June 202545
May 202579
April 2025101
March 202593
February 202569
January 202591
December 202489
November 202477
October 202474
September 202481

Show more Show less

Labels

How do you detect lung cancer early
how to cure lung cancer at home
IFTTT
Lung Cancer
lung cancer causes
lung cancer stages
lung cancer symptoms
lung cancer treatment
metastatic lung cancer
signs of lung cancer

signs+of+lung+cancer
stage 4 lung cancer
symptoms of lung cancer in females
types of lung cancer
What are the first signs of lung cancer UK
what is lung cancer

Show more Show less